A PK Study to Assess the Drug-drug Interaction of a Strong CYP2C8 Inhibitor on Adagrasib
Clinical trial NCT05868356 · COMPLETED
Trial details
- NCT number
- NCT05868356
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-01
- Primary completion
- 2023-07-25
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.